EC Number | Application | Comment | Organism |
---|---|---|---|
1.5.1.3 | medicine | enzyme is a target of several anti-folate inhibitory drugs to combat bacteria, protozoa and cancer | Plasmodium vivax |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.5.1.3 | DNA-sequence analysis | Plasmodium vivax |
1.5.1.3 | expression in Escherichia coli of wild-type and mutant enzymes | Plasmodium vivax |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.5.1.3 | S58R/S117N | double mutant with naturally occurring point mutations, antifolate drug resistant | Plasmodium vivax |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.5.1.3 | cycloguanil | wild-type and mutant | Plasmodium vivax | |
1.5.1.3 | methotrexate | wild-type and mutant | Plasmodium vivax | |
1.5.1.3 | pyrimethamine | wild-type and mutant | Plasmodium vivax | |
1.5.1.3 | trimethoprim | wild-type and mutant | Plasmodium vivax |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.5.1.3 | 0.06 | - |
NADPH | wild-type enzyme | Plasmodium vivax | |
1.5.1.3 | 0.07 | - |
NADPH | mutant enzyme | Plasmodium vivax | |
1.5.1.3 | 0.097 | - |
7,8-dihydrofolate | mutant enzyme | Plasmodium vivax | |
1.5.1.3 | 0.107 | - |
7,8-dihydrofolate | wild-type enzyme | Plasmodium vivax |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.5.1.3 | 7,8-dihydrofolate + NADPH | Plasmodium vivax | DHFR activity is not essential for virus replication | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.5.1.3 | Plasmodium vivax | - |
wild-type and mutant enzymes recombinant from Escherichia coli | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.5.1.3 | recombinant from Escherichia coli | Plasmodium vivax |
EC Number | Renatured (Comment) | Organism |
---|---|---|
1.5.1.3 | wild-type and mutant, renaturation from inclusion bodies due to expression in E. coli, 200 mM KCl, 20 mM potassium phosphate, pH 7.0, 0.1 mM EDTA, 10 mM dithiothreitol | Plasmodium vivax |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.5.1.3 | 1.7 | - |
purified recombinant enzyme | Plasmodium vivax |
EC Number | Storage Stability | Organism |
---|---|---|
1.5.1.3 | -20°C, several months | Plasmodium vivax |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.5.1.3 | 7,8-dihydrofolate + NADPH | - |
Plasmodium vivax | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? | |
1.5.1.3 | 7,8-dihydrofolate + NADPH | DHFR activity is not essential for virus replication | Plasmodium vivax | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.5.1.3 | 25 | - |
assay at | Plasmodium vivax |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.5.1.3 | NADPH | - |
Plasmodium vivax |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.5.1.3 | 0.0000052 | - |
methotrexate | wild-type enzyme | Plasmodium vivax | |
1.5.1.3 | 0.0000069 | - |
methotrexate | mutant enzyme | Plasmodium vivax | |
1.5.1.3 | 0.000064 | - |
pyrimethamine | wild-type enzyme | Plasmodium vivax | |
1.5.1.3 | 0.000067 | - |
cycloguanil | wild-type enzyme | Plasmodium vivax | |
1.5.1.3 | 0.000098 | - |
trimethoprim | wild-type enzyme | Plasmodium vivax | |
1.5.1.3 | 0.000143 | - |
trimethoprim | mutant enzyme | Plasmodium vivax | |
1.5.1.3 | 0.000743 | - |
cycloguanil | mutant enzyme | Plasmodium vivax | |
1.5.1.3 | 0.00093 | - |
pyrimethamine | mutant enzyme | Plasmodium vivax |